Non disponible en dehors du Royaume-Uni et de l'Irlande
Application
Azelaoyl PAF is a potent PPARγ agonist. Azelaoyl PAF has been used to investigate whether peroxisome proliferator-activated receptors gamma agonists could play a role in the treatment of Friedreich′s ataxia, a neurodegenerative disease due to frataxin deficiency.
Biochem/physiol Actions
Potent PPARγ agonist.
Features and Benefits
This compound is featured on the Nuclear Receptors (PPARs) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
Ce produit répond aux critères suivants pour être admissible aux récompenses suivantes :